Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06102395
Status:
RECRUITING
Last Update Posted:
2023-10-30
First Post:
2023-04-12
Brief Title:
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced LA HNSCC
Sponsor:
Beijing Tongren Hospital
Organization:
Beijing Tongren Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pembrolizumab |
| Head and Neck Squamous Cell Carcinoma |
| Neoadjuvant Therapy |
Keywords: